Moreover, TREM2 inhibited macrophage-expressed antigen-presenting molecules MHC-I/II (Fig. 5K and L) and the coactivators CD80/CD86 (Fig. 5I and J), suggesting that TREM2 also affects T cell-mediated anti-tumor immune response. Here, CD86 is linked to neoplasm.